← back to search

John P. Dekker

National Institutes of Health · US
Area of research
Molecular Medicine · Clinical Biochemistry
Research interest
Research interests include Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing, Genomics and Phylogenetic Studies, and Antibiotic Use and Resistance.
h-index
37
citations
5,953
works
138
NIH funding
primary concept
Medicine
email

Recent publications

Improved Cas9-targeted nanopore sequencing facilitates ultra-deep analysis of genomic variation
Cell Reports Methods 2026cited by 0position: contributordoi
An open-source nanopore-only sequencing workflow for analysis of clonal outbreaks delivers short-read level accuracy.
2025cited by 5position: contributordoi
Transcriptional diversification in a human-adapting zoonotic pathogen drives niche-specific evolution.
2025cited by 1position: contributordoi
Efflux pump-mediated resistance to new beta lactam antibiotics in multidrug-resistant gram-negative bacteria.
2024cited by 28position: contributordoi
Bactericidal antibiotic treatment induces damaging inflammation via TLR9 sensing of bacterial DNA.
2024cited by 7position: contributordoi
Regional centromere configuration in the fungal pathogens of the <i>Pneumocystis</i> genus.
2024cited by 5position: contributordoi
Whole-genome sequence of <i>Mucor velutinosus</i> NIH1002, a strain associated with disseminated disease.
2024cited by 1position: contributordoi
Roving methyltransferases generate a mosaic epigenetic landscape and influence evolution in Bacteroides fragilis group.
2023cited by 8position: contributordoi
Comparative Evaluation of Current Biochemical-, Sequencing-, and Proteomic-Based Identification Methods for the Streptococcus bovis Group.
2023cited by 5position: contributordoi
Trimethoprim-Sulfamethoxazole Versus Levofloxacin for <i>Stenotrophomonas maltophilia</i> Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals
Open Forum Infectious Diseases 2022cited by 48position: middledoi
Hypermutator strains of Pseudomonas aeruginosa reveal novel pathways of resistance to combinations of cephalosporin antibiotics and beta-lactamase inhibitors.
2022cited by 14position: contributordoi
Disseminated <i>Mycoplasma Orale</i> Infection in Patients With Phosphoinositide-3-Kinase Regulatory Subunit 1 Mutations.
2022cited by 1position: contributordoi
Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020
Annals of Internal Medicine 2021cited by 212position: middledoi
In vivo evolution of an emerging zoonotic bacterial pathogen in an immunocompromised human host.
2021cited by 13position: contributordoi
Manual Reading of Sensititre Broth Microdilution System Panels Improves Accuracy of Susceptibility Reporting for Polymyxin Antibiotics
Journal of Clinical Microbiology 2021cited by 4position: contributordoi
Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use
JAMA Network Open 2020cited by 385position: middledoi
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals
The Lancet Infectious Diseases 2020cited by 264position: middledoi
Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study
The Lancet Infectious Diseases 2020cited by 120position: middledoi
A Phylogeny-Informed Proteomics Approach for Species Identification within the Burkholderia cepacia Complex.
2020cited by 4position: contributordoi
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents
Clinical Infectious Diseases 2018cited by 559position: middledoi
Severe BCG-osis Misdiagnosed as Multidrug-Resistant Tuberculosis in an IL-12Rβ1-Deficient Peruvian Girl
Journal of Clinical Immunology 2018cited by 12position: middledoi
Multi-institute analysis of carbapenem resistance reveals remarkable diversity, unexplained mechanisms, and limited clonal outbreaks
Proceedings of the National Academy of Sciences 2017cited by 168position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 14 papers (2020–2026)Robert L. Danner · National Institutes of Health6 papers (2018–2022)Sameer S. Kadri · National Institutes of Health Clinical Center6 papers (2018–2022)Ahmed Babiker · Emory University4 papers (2020–2022)Chanu Rhee · Harvard University4 papers (2018–2021)Yi Ling Lai · Chinese Academy of Sciences4 papers (2018–2022)Sarah Warner · National Heart Lung and Blood Institute4 papers (2020–2022)Michael Klompas · Harvard University4 papers (2018–2021)John H. Powers · Uniformed Services University of the Health Sciences3 papers (2018–2021)Jeffrey R. Strich · National Institutes of Health3 papers (2020–2021)Emily Ricotta · Research Network (United States)3 papers (2018–2021)Alicen B. Spaulding · Children's Minnesota2 papers (2018–2021)Cumhur Y. Demirkale · National Institutes of Health2 papers (2020–2021)Steven M. Holland · Amsterdam University Medical Centers2 papers (2018–2022)Tara N. Palmore · National Institutes of Health2 papers (2018–2020)Junfeng Sun · Chinese Academy of Agricultural Sciences2 papers (2021–2022)Jennifer Adjemian · National Institutes of Health2 papers (2018–2020)Ousmane H. Cissé · Duke University2 papers (2020–2024)Pavel P Khil · National Human Genome Research Institute2 papers (2022–2025)Sadia Sarzynski · National Heart Lung and Blood Institute2 papers (2020–2022)